US10590419B2ActiveUtilityA1

MicroRNA induction of cardiac regeneration

75
Assignee: UNIV PENNSYLVANIAPriority: May 16, 2014Filed: May 15, 2015Granted: Mar 17, 2020
Est. expiryMay 16, 2034(~7.8 yrs left)· nominal 20-yr term from priority
A01K 2267/0375C12N 5/0657C12N 15/113A01K 2227/105C12N 2740/15043C12N 2310/141C12N 2510/00C12N 2501/65A61K 31/19A61K 31/7105A61K 48/0075C12N 2320/35A61K 48/0058C12N 2320/32C12N 15/86C12N 5/0662C12N 15/1137
75
PatentIndex Score
3
Cited by
44
References
13
Claims

Abstract

The invention relates to compostions and methods for promoting cellular proliferation and de-differentiation of cells into stem cells to foster tissue regeneration. Specifically, the invention relates to transiently administering a microRNA (miR) or its mimic for promoting cardiomyocyte proliferation and cardiac regeneration.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering locally to the heart of said subject a composition comprising a microRNA (miR) 302-367 cluster or a miR 302-367 cluster mimic, wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes. 
     
     
       2. The method of  claim 1 , wherein the transient administration comprises a single administration of the composition to the subject. 
     
     
       3. The method of  claim 1 , wherein the composition comprises valproic acid. 
     
     
       4. The method of  claim 1 , wherein said miR is operably linked to a regulatory sequence. 
     
     
       5. The method of  claim 4 , wherein said regulatory sequence is an inducible promoter. 
     
     
       6. The method of  claim 5 , wherein said inducible promoter is a doxycycline inducible promoter. 
     
     
       7. The method of  claim 1 , wherein said miR is encoded by a nucleic acid sequence present within a vector. 
     
     
       8. The method of  claim 7 , wherein the vector is a viral vector. 
     
     
       9. The method of  claim 8 , wherein the viral vector is a lentivirus vector. 
     
     
       10. The method of  claim 7 , wherein the vector is a plasmid vector. 
     
     
       11. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering locally to the heart of said subject a composition comprising a microRNA (miR) cluster or its mimic, wherein said cluster comprises one or more of miR302b and miR302c or two or more of miR302b, miR302c, and miR367, and wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes. 
     
     
       12. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering intravenously at least once daily for 7 days said subject a composition comprising a microRNA (miR) 302-367 cluster or a miR 302-367 cluster mimic, wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes. 
     
     
       13. A method for promoting cardiac repair and regeneration in a subject, the method comprising: transiently administering intravenously at least once daily for 7 days said subject a composition comprising a microRNA (miR) cluster or its mimic, wherein said cluster comprises one or more of miR302b and miR302c or two or more of miR302b, miR302c, and miR367, and wherein said transient administration is sufficient to transiently activate cardiomyocyte proliferation, but not to persistently reactivate the cell cycle of postnatal cardiomyocytes.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.